Urology
Volume 59, Issue 6 , Pages 816-820 , June 2002

Natural history of chronic renal insufficiency after partial and radical nephrectomy

  • James McKiernan

      Affiliations

    • Department of Urology, Memorial Sloan-Kettering Cancer Center, New York, New York, USA
    • ,
  • Rachel Simmons

      Affiliations

    • Department of Urology, Memorial Sloan-Kettering Cancer Center, New York, New York, USA
    • ,
  • Jared Katz

      Affiliations

    • Department of Urology, Memorial Sloan-Kettering Cancer Center, New York, New York, USA
    • ,
  • Paul Russo

      Affiliations

    • Dr. McKiernan is currently at the Department of Urology, Columbia University College of Physicians and Surgeons, Herbert Irving Comprehensive Cancer Center, 161 Fort Washington Avenue, New York, NY 10032
    • Corresponding Author InformationReprint requests: Paul Russo, M.D., Department of Urology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, C-1064, New York, NY 10021 USA
    • Department of Urology, Memorial Sloan-Kettering Cancer Center, New York, New York, USA

Received 9 May 2001 ,Revised 13 December 2001 ,Accepted 13 December 2001.

References 

  1. Konnak JW, Grossman HB. Renal cell carcinoma as an incidental finding. J Urol. 1990;134:1094–1096
  2. Chow WH, Devesa SS, Warren JL, et al.  Rising incidence of renal cell cancer in the United States. JAMA. 1999;281:1628–1631
  3. Russo P. Renal cell carcinoma (presentation, staging, and surgical treatment). Semin Oncol. 2000;27:160–176
  4. Robson CJ. Radical nephrectomy for renal cell carcinoma. J Urol. 1963;89:37–42
  5. Lee CT, Katz J, Shi W, et al.  Surgical management of renal tumors 4 cm or less in a contemporary cohort. J Urol. 2000;163:730–736
  6. Belldegrun A, Tsui KH, deKernion JB, et al.  Efficacy of nephron-sparing surgery for renal cell carcinoma (analysis based on the new 1997 tumor-node-metastasis staging system). J Clin Oncol. 1999;17:2868–2875
  7. Novick AC. Renal-sparing surgery for renal cell carcinoma. Urol Clin North Am. 1993;20:277–282
  8. Fergany AF, Hafez KS, Novick AC. Long-term results of nephron sparing surgery for localized renal cell carcinoma (10-year followup). J Urol. 2000;163:442–445
  9. Najarian JS, Chavers BM, McHugh LE, et al.  20 years or more of follow-up of living kidney donors. Lancet. 1992;340:807–810
  10. Riehle RA, Steckler R, Naslund EB, et al.  Selection criteria for the evaluation of living related renal donors. J Urol. 1990;144:845–848
  11. Motzer RJ, Bander NH, Nanus DM. Renal-cell carcinoma. N Engl J Med. 1996;335:865–875
  12. Orth SR. Smoking—a renal risk factor. Nephron. 2000;86:12–26
  13. He J, Whelton PK. Elevated systolic blood pressure and risk of cardiovascular and renal disease (overview of evidence from observational epidemiologic studies and randomized controlled trials). Am Heart J. 1999;138:211–219
  14. Wolters U, Wolf T, Stutzer H, et al.  ASA classification and perioperative variables as predictors of postoperative outcome. Br J Anaesth. 1996;77:217–222
  15. Kovacs G, Akhtar M, Beckwith BJ, et al.  The Heidelberg classification of renal cell tumours. J Pathol. 1997;183:131–133
  16. Hostetter TH, Olson JL, Rennke HG, et al.  Hyperfiltration in remnant nephrons (a potentially adverse response to renal ablation). Am J Physiol. 1981;241:F85–F93
  17. Wishnow KI, Johnson DE, Preston D, et al.  Long-term serum creatinine values after radical nephrectomy. Urology. 1990;35:114–116
  18. Butler BP, Novick AC, Miller DP, et al.  Management of small unilateral renal cell carcinomas (radical versus nephron-sparing surgery). Urology. 1995;45:34–41
  19. Lau WK, Blute ML, Weaver AL, et al.  Matched comparison of radical nephrectomy vs nephron-sparing surgery in patients with unilateral renal cell carcinoma and a normal contralateral kidney. Mayo Clin Proc. 2000;75:1236–1242
  20. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457–467
  21. Hsu CY, Chertow GM. Chronic renal confusion (insufficiency, failure, dysfunction, or disease). Am J Kidney Dis. 2000;36:415–418
  22. Culleton BF, Larson MG, Evans JC, et al.  Prevalence and correlates of elevated serum creatinine levels (the Framingham Heart Study). Arch Intern Med. 1999;159:1785–1790
  23. Iseki K, Ikemiya Y, Fukiyama K. Risk factors of end-stage renal disease and serum creatinine in a community-based mass screening. Kidney Int. 1997;51:850–854
  24. Anderson RN. United States life tables, 1997. Natl Vital Stat Rep. 1999;47:1–37

PII: S0090-4295(02)01501-7

Urology
Volume 59, Issue 6 , Pages 816-820 , June 2002

Article Tools

* Image Usage & Resolution